Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Schizophrenia Treatments Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Atypical Antipsychotics
1.2.3 Phenothiazine Antipsychotics
1.2.4 Thioxanthenes
1.2.5 Miscellaneous Antipsychotic Agents
1.3 Market by Application
1.3.1 Global Schizophrenia Treatments Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.3.4 Retail Pharmacies
1.3.5 E-Commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Schizophrenia Treatments Market Perspective (2018-2033)
2.2 Schizophrenia Treatments Growth Trends by Region
2.2.1 Global Schizophrenia Treatments Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Schizophrenia Treatments Historic Market Size by Region (2018-2023)
2.2.3 Schizophrenia Treatments Forecasted Market Size by Region (2024-2033)
2.3 Schizophrenia Treatments Market Dynamics
2.3.1 Schizophrenia Treatments Industry Trends
2.3.2 Schizophrenia Treatments Market Drivers
2.3.3 Schizophrenia Treatments Market Challenges
2.3.4 Schizophrenia Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Schizophrenia Treatments Players by Revenue
3.1.1 Global Top Schizophrenia Treatments Players by Revenue (2018-2023)
3.1.2 Global Schizophrenia Treatments Revenue Market Share by Players (2018-2023)
3.2 Global Schizophrenia Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Schizophrenia Treatments Revenue
3.4 Global Schizophrenia Treatments Market Concentration Ratio
3.4.1 Global Schizophrenia Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Schizophrenia Treatments Revenue in 2022
3.5 Schizophrenia Treatments Key Players Head office and Area Served
3.6 Key Players Schizophrenia Treatments Product Solution and Service
3.7 Date of Enter into Schizophrenia Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Schizophrenia Treatments Breakdown Data by Type
4.1 Global Schizophrenia Treatments Historic Market Size by Type (2018-2023)
4.2 Global Schizophrenia Treatments Forecasted Market Size by Type (2024-2033)
5 Schizophrenia Treatments Breakdown Data by Application
5.1 Global Schizophrenia Treatments Historic Market Size by Application (2018-2023)
5.2 Global Schizophrenia Treatments Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Schizophrenia Treatments Market Size (2018-2033)
6.2 North America Schizophrenia Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Schizophrenia Treatments Market Size by Country (2018-2023)
6.4 North America Schizophrenia Treatments Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Schizophrenia Treatments Market Size (2018-2033)
7.2 Europe Schizophrenia Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Schizophrenia Treatments Market Size by Country (2018-2023)
7.4 Europe Schizophrenia Treatments Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Schizophrenia Treatments Market Size (2018-2033)
8.2 Asia-Pacific Schizophrenia Treatments Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Schizophrenia Treatments Market Size by Region (2018-2023)
8.4 Asia-Pacific Schizophrenia Treatments Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Schizophrenia Treatments Market Size (2018-2033)
9.2 Latin America Schizophrenia Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Schizophrenia Treatments Market Size by Country (2018-2023)
9.4 Latin America Schizophrenia Treatments Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Schizophrenia Treatments Market Size (2018-2033)
10.2 Middle East & Africa Schizophrenia Treatments Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Schizophrenia Treatments Market Size by Country (2018-2023)
10.4 Middle East & Africa Schizophrenia Treatments Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson
11.1.1 Johnson and Johnson Company Detail
11.1.2 Johnson and Johnson Business Overview
11.1.3 Johnson and Johnson Schizophrenia Treatments Introduction
11.1.4 Johnson and Johnson Revenue in Schizophrenia Treatments Business (2018-2023)
11.1.5 Johnson and Johnson Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Schizophrenia Treatments Introduction
11.2.4 Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2018-2023)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Otsuka
11.3.1 Otsuka Company Detail
11.3.2 Otsuka Business Overview
11.3.3 Otsuka Schizophrenia Treatments Introduction
11.3.4 Otsuka Revenue in Schizophrenia Treatments Business (2018-2023)
11.3.5 Otsuka Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Schizophrenia Treatments Introduction
11.4.4 AstraZeneca Revenue in Schizophrenia Treatments Business (2018-2023)
11.4.5 AstraZeneca Recent Development
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Detail
11.5.2 Sumitomo Dainippon Pharma Business Overview
11.5.3 Sumitomo Dainippon Pharma Schizophrenia Treatments Introduction
11.5.4 Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2018-2023)
11.5.5 Sumitomo Dainippon Pharma Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Schizophrenia Treatments Introduction
11.6.4 Eli Lilly Revenue in Schizophrenia Treatments Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 Alkermes
11.7.1 Alkermes Company Detail
11.7.2 Alkermes Business Overview
11.7.3 Alkermes Schizophrenia Treatments Introduction
11.7.4 Alkermes Revenue in Schizophrenia Treatments Business (2018-2023)
11.7.5 Alkermes Recent Development
11.8 Vanda Pharmaceuticals
11.8.1 Vanda Pharmaceuticals Company Detail
11.8.2 Vanda Pharmaceuticals Business Overview
11.8.3 Vanda Pharmaceuticals Schizophrenia Treatments Introduction
11.8.4 Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2018-2023)
11.8.5 Vanda Pharmaceuticals Recent Development
11.9 ALLERGAN
11.9.1 ALLERGAN Company Detail
11.9.2 ALLERGAN Business Overview
11.9.3 ALLERGAN Schizophrenia Treatments Introduction
11.9.4 ALLERGAN Revenue in Schizophrenia Treatments Business (2018-2023)
11.9.5 ALLERGAN Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Detail
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Schizophrenia Treatments Introduction
11.10.4 Pfizer Revenue in Schizophrenia Treatments Business (2018-2023)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Schizophrenia Treatments Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Atypical Antipsychotics
Table 3. Key Players of Phenothiazine Antipsychotics
Table 4. Key Players of Thioxanthenes
Table 5. Key Players of Miscellaneous Antipsychotic Agents
Table 6. Global Schizophrenia Treatments Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Schizophrenia Treatments Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Schizophrenia Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Schizophrenia Treatments Market Share by Region (2018-2023)
Table 10. Global Schizophrenia Treatments Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Schizophrenia Treatments Market Share by Region (2024-2033)
Table 12. Schizophrenia Treatments Market Trends
Table 13. Schizophrenia Treatments Market Drivers
Table 14. Schizophrenia Treatments Market Challenges
Table 15. Schizophrenia Treatments Market Restraints
Table 16. Global Schizophrenia Treatments Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Schizophrenia Treatments Market Share by Players (2018-2023)
Table 18. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Treatments as of 2022)
Table 19. Ranking of Global Top Schizophrenia Treatments Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Schizophrenia Treatments Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Schizophrenia Treatments Product Solution and Service
Table 23. Date of Enter into Schizophrenia Treatments Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Schizophrenia Treatments Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Schizophrenia Treatments Revenue Market Share by Type (2018-2023)
Table 27. Global Schizophrenia Treatments Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Schizophrenia Treatments Revenue Market Share by Type (2024-2033)
Table 29. Global Schizophrenia Treatments Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Schizophrenia Treatments Revenue Market Share by Application (2018-2023)
Table 31. Global Schizophrenia Treatments Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Schizophrenia Treatments Revenue Market Share by Application (2024-2033)
Table 33. North America Schizophrenia Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Schizophrenia Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Schizophrenia Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Schizophrenia Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Schizophrenia Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Schizophrenia Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Schizophrenia Treatments Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Schizophrenia Treatments Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Schizophrenia Treatments Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Schizophrenia Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Schizophrenia Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Schizophrenia Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Schizophrenia Treatments Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Schizophrenia Treatments Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Schizophrenia Treatments Market Size by Country (2024-2033) & (US$ Million)
Table 48. Johnson and Johnson Company Detail
Table 49. Johnson and Johnson Business Overview
Table 50. Johnson and Johnson Schizophrenia Treatments Product
Table 51. Johnson and Johnson Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 52. Johnson and Johnson Recent Development
Table 53. Bristol-Myers Squibb Company Detail
Table 54. Bristol-Myers Squibb Business Overview
Table 55. Bristol-Myers Squibb Schizophrenia Treatments Product
Table 56. Bristol-Myers Squibb Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 57. Bristol-Myers Squibb Recent Development
Table 58. Otsuka Company Detail
Table 59. Otsuka Business Overview
Table 60. Otsuka Schizophrenia Treatments Product
Table 61. Otsuka Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 62. Otsuka Recent Development
Table 63. AstraZeneca Company Detail
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Schizophrenia Treatments Product
Table 66. AstraZeneca Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Sumitomo Dainippon Pharma Company Detail
Table 69. Sumitomo Dainippon Pharma Business Overview
Table 70. Sumitomo Dainippon Pharma Schizophrenia Treatments Product
Table 71. Sumitomo Dainippon Pharma Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 72. Sumitomo Dainippon Pharma Recent Development
Table 73. Eli Lilly Company Detail
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Schizophrenia Treatments Product
Table 76. Eli Lilly Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. Alkermes Company Detail
Table 79. Alkermes Business Overview
Table 80. Alkermes Schizophrenia Treatments Product
Table 81. Alkermes Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 82. Alkermes Recent Development
Table 83. Vanda Pharmaceuticals Company Detail
Table 84. Vanda Pharmaceuticals Business Overview
Table 85. Vanda Pharmaceuticals Schizophrenia Treatments Product
Table 86. Vanda Pharmaceuticals Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 87. Vanda Pharmaceuticals Recent Development
Table 88. ALLERGAN Company Detail
Table 89. ALLERGAN Business Overview
Table 90. ALLERGAN Schizophrenia Treatments Product
Table 91. ALLERGAN Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 92. ALLERGAN Recent Development
Table 93. Pfizer Company Detail
Table 94. Pfizer Business Overview
Table 95. Pfizer Schizophrenia Treatments Product
Table 96. Pfizer Revenue in Schizophrenia Treatments Business (2018-2023) & (US$ Million)
Table 97. Pfizer Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Schizophrenia Treatments Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Schizophrenia Treatments Market Share by Type: 2022 VS 2033
Figure 3. Atypical Antipsychotics Features
Figure 4. Phenothiazine Antipsychotics Features
Figure 5. Thioxanthenes Features
Figure 6. Miscellaneous Antipsychotic Agents Features
Figure 7. Global Schizophrenia Treatments Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Schizophrenia Treatments Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. E-Commerce Case Studies
Figure 13. Schizophrenia Treatments Report Years Considered
Figure 14. Global Schizophrenia Treatments Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Schizophrenia Treatments Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Schizophrenia Treatments Market Share by Region: 2022 VS 2033
Figure 17. Global Schizophrenia Treatments Market Share by Players in 2022
Figure 18. Global Top Schizophrenia Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Schizophrenia Treatments as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Schizophrenia Treatments Revenue in 2022
Figure 20. North America Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Schizophrenia Treatments Market Share by Country (2018-2033)
Figure 22. United States Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Schizophrenia Treatments Market Share by Country (2018-2033)
Figure 26. Germany Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Schizophrenia Treatments Market Share by Region (2018-2033)
Figure 34. China Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Schizophrenia Treatments Market Share by Country (2018-2033)
Figure 42. Mexico Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Schizophrenia Treatments Market Share by Country (2018-2033)
Figure 46. Turkey Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Schizophrenia Treatments Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Johnson and Johnson Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 50. Otsuka Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 52. Sumitomo Dainippon Pharma Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 53. Eli Lilly Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 54. Alkermes Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 55. Vanda Pharmaceuticals Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 56. ALLERGAN Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 57. Pfizer Revenue Growth Rate in Schizophrenia Treatments Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed